Aspartyl, arginyl and alanyl aminopeptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats

Brain Research

Volumn 1170, Issue SUPPL.: COMPLETE, 2007, Pages 112-118

  Zambotti Villela, Leonardo ^a   Yamasaki, Simone C ^a   Villarroel, Joyce S ^a   Alponti, Rafaela F ^a   Silveira, Paulo F ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Hippocampus; Hypothalamus; Peptidases; Peptide; Proteases; STZ diabetes

Indexed keywords

AMINOPEPTIDASE B; ANGIOTENSIN; ASPARTYL AMINOPEPTIDASE; BRADYKININ; ENKEPHALIN; GLUCOSE; INSULIN; MICROSOMAL AMINOPEPTIDASE; OXYTOCIN; PUROMYCIN; STREPTOZOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY BALANCE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; HIPPOCAMPUS; HOMEOSTASIS; HYDROLYSIS; HYPOTHALAMUS; IN VITRO STUDY; INSULIN TREATMENT; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT; STREPTOZOCIN DIABETES;

AMINOPEPTIDASES; ANIMALS; ANTIGENS, CD13; BLOOD PRESSURE; BRAIN DISEASES, METABOLIC; CELL MEMBRANE; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; ENDOCRINE SYSTEM DISEASES; GLUTAMYL AMINOPEPTIDASE; HIPPOCAMPUS; HOMEOSTASIS; HYPOTHALAMUS; INSULIN; MALE; NEURONS; NEUROPEPTIDES; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; RATS; RATS, WISTAR; WATER-ELECTROLYTE BALANCE;

RATTUS;

EID: 34548481975     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.026     Document Type: Article

References (40)

1. Akaishi T., and Homma S. Hypothalamic osmoregulation for vasopressin release in streptozotocin-diabetic rats in vivo and in vitro. Brain Res. 569 (1992) 86-92
2. Bergmeyer H.U., and Brent E. Assay with pyruvate and NADH. Methods in Enzymatic Analysis vol. 2, ed (1972), Academic Press, London 574-577
3. Biessels G.J., van der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441 (2002) 1-14
4. Blume A., Undeutsch C., Zhao Y., Kaschina E., Culman J., and Unger T. ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am. J. Physiol., Regul. Integr. Comp. Physiol. 289 (2005) 845-850
5. Bracci L., Falciani C., Lelli B., Lozzi L., Runci Y., Pini A., De Montis M.G., Tagliamonte A., and Neri P. Synthetic peptides in the form of dendrimers become resistant to protease activity. J. Biol. Chem. 278 (2003) 46590-46595
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Bunnemann, B., Fuxe, K., Bjelke, B., Ganten, D., 1991. The brain renin-angiotensin system and its possible involvement in volume transmission. In K Fuxe, L.F. Agnati (Eds), Volume transmission in the brain: Novel mechanisms for neural transmission. ed. Raven Press, New York, pp. 131-158.
8. Cheung H.S., and Cushman D.W. A soluble aspartate aminopeptidase from dog kidney. Biochim. Biophys. Acta 242 (1971) 190-193
9. Faber F., Gembardt F., Sun X., Mizutani S., Siems W.E., and Walther T. Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice. Regul. Pept. 136 (2006) 130-137
10. Frankish H.M., Dryden S., Hopkins D., Wang Q., and Williams G. Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 16 (1995) 757-771
11. Frerker N., Wagner L., Wolf R., Heiser U., Hoffmann T., Rahfeld J.U., Schade J., Karl T., Naim H.Y., Alfalah M., Demuth H.U., and von Hörsten S. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Peptides 28 (2007) 257-268
12. Gillespie T.J., Konings P.N., Merrill B.J., and Davis T.P. A specific enzyme assay for aminopeptidase M in rat brain. Life Sci. 51 (1992) 2097-2106
13. Gomez S., Gluschankof P., Lepage A., and Cohen P. Relationship between endo- and exopeptidases in a processing enzyme system: activation of an endoprotease by the aminopeptidase B-like activity in somatostatin-28 convertase. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 5468-5472
14. Hamel F.G., Fawcett J., Andersen C.I., Berhanu P., Bennett R.G., and Duckworth W.C. Insulin inhibition of protein degradation in cells expressing wild-type and mutant insulin receptors. J. Endocrinol. Invest. 26 (2003) 1088-1094
15. Harding J.W., Yoshida M.S., Dilts R.P., Woods T.M., and Wright J.W. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. J. Neurochem. 46 (1986) 1292-1297
16. Hui K.S. Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration. Neurochem. Res. (2007) (PMID: 17476590. May 03, 2007, 10.1007/s11064-007-9356-3)
17. Hui K.S., Graf L., and Lajtha A. Beta-endorphin inhibits met-enkephalin breakdown by a brain aminopeptidase: structure-activity relationships. Biochem. Biophys. Res. Commun. 105 (1982) 1482-1487
18. Hwang S.-R., O'Neill A., Bark S., Foulon T., and Hook V. Secretory vesicle aminopeptidase B related to neuropeptide processing: molecular identification and subcellular localization to enkephalin- and NPY-containing chromaffin granules. J. Neurochem. 100 (2007) 1340-1350
19. Kokkonen J.O., Kuoppala A., Saarinen J., Lindstedt K.A., and Kovanen P.T. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Circulation 99 (1999) 1984-1990
20. LaBella F.S., Geiger J.D., and Glavin G.B. Administered peptides inhibit the degradation of endogenous peptides. The dilemma of distinguishing direct from indirect effects. Peptides 6 (1985) 645-660
21. Mantle M. Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues. Clin. Chim. Acta 207 (1992) 107-118
22. Martín F.J., Míguez J.M., Aldegunde M., and Atienza G. Effect of streptozotocin-induced diabetes mellitus on serotonin measures of peripheral tissues in rats. Life Sci. 56 (1995) 51-59
23. Matsumura K., Tsuchihashi T., Fujii K., and Iida M. Neural regulation of blood pressure by leptin and the related peptides. Regul. Pept. 114 (2003) 79-86
24. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., and Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35 (2003) 901-918
25. Meece J. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr. Med. Res. Opin. 23 (2007) 933-944
26. Mitsui T., Nomura S., Itakura A., and Mizutani S. Role of aminopeptidases in the blood pressure regulation. Biol. Pharm. Bull. 27 (2004) 768-771
27. Molinaro G., Duan Q.L., Chagnon M., Moreau M.E., Simon P., Clavel P., Lavaud S., Boileau G., Rouleau G.A., Lepage Y., Adam A., and Chanard J. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney Int. 70 (2006) 1823-1831
28. O'Cuinn G. Peptide metabolism in cytoplasm of brain cells. Biochem. Soc. trans. 26 (1998) 279-291
29. Obici S., and Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144 (2003) 5172-5178
30. Ramírez-Expósito M.J., García M.J., Mayas M.D., Ramírez M., and Martínez-Martos J.M. Differential effects of dietary cholesterol on aminopeptidase A, B and M in the frontal cortex of male and female mice. Nutr. Neurosci. 4 (2001) 461-468
31. Reis W.L., Giusti-Paiva A., Ventura R.R., Margatho L.O., Gomes D.A., Elias L.L., and Antunes-Rodrigues J. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release, antidiuretic and natriuretic responses induced by central angiotensin-II in conscious rats. Exp. Physiol. (2007) (PMID: 17513344. May 18, 2007, 10.1113/expphysiol.2007.037911)
32. Saavedra J.M. Brain and pituitary angiotensin in the central nervous system. Endocr. Rev. 13 (1992) 329-380
33. Serino R., Ueta Y., Tokunaga M., Hara Y., Nomura M., Kabashima N., Shibuya I., Hattori Y., and Yamashita H. Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats. Diabetologia 41 (1998) 640-648
34. Waldegger S., Busch G.L., Kaba N.K., Zempel G., Ling H., Heidland A., Haussinger D., and Lang F. Effect of cellular hydration on protein metabolism. Miner. Electrolyte Metab. 23 (1997) 201-205
35. Wolf G., Wenzel U., Assamann K.J.M., and Stahl R.A.K. Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension. Nephrol. Dial. Transplant. 15 (2000) 1935-1942
36. Wright J.W., and Harding J.W. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog. Neurobiol. 72 (2004) 263-293
37. Wright J.W., Krebs L.T., Stobb J.W., and Harding J.W. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16 (1995) 23-52
38. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P., and LlorensCortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11968-11973
39. Zini S., Masdehors P., Lenkei Z., Fournie-Zaluski M.C., Roques B.P., Corvol P., and LlorensCortes C. Aminopeptidase A: distribution in rat brain nuclei and increases activity in spontaneously hypertensive rats. Neuroscience 78 (1997) 1187-1193
40. Zini S., Demassey Y., FournieZaluski M.C., Bischoff L., Corvol P., LlorensCortes C., and Sanderson P. Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. NeuroReport 9 (1998) 825-828